Skip to main content
Log in

Tc-99m-HMDP bone uptake quantification and plasma osteocalcin levels in hemodialysis patients—A preliminary study

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

In this preliminary study plasma osteocalcin levels and Tc-99m-HMDP (Technetium 99m hydroxymetylene diphosphonate) bone uptake (BU) were measured in 10 chronic end-stage renal failure patients who were on maintenance hemodialysis. The aim of this study was to determine the correlation between bone uptake and osteocalcin-a sensitive and specific marker of osteoblastic activity. There was a statistically significant increase in both 20 and 180 minute uptake in the patient group (36±2.7 and 39±3.6) when compared to the normal volunteers (32±3.1 and 19±2.7). Plasma osteocalcin levels were also significantly high (24.5±5.6 ng/ml) when compared with normal values (6.5±2.3 ng/ml). The correlations between osteocalcin and 20 and 180 min BU were high (r=0.62 and 0.72 respectively). In conclusion, our preliminary study suggests that, in hemodialysis patients, Tc-99m-HMDP bone uptake quantification is a sensitive and non-invasive method for showing increased osteoblastic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Malluche HH, et al: The value of bone biopsies for diagnosis of renal bone disease. Dialysis Transplantation.Nephrology, pp 111–115, 1973

  2. Sebert JL, et al: Plasma Bone-GLA Protein: Assessment of its clinical value as an index of bone turnover and bone formation in hemodialysis patients.Proc EDTA-ERA 22: 1218, 1985

    Google Scholar 

  3. Malluche HH, et al: Plasma levels of bone GLA-protein reflect bone formation in patients on chronic maintenance dialysis.Kidney Int 26: 869, 1984

    Article  PubMed  CAS  Google Scholar 

  4. Hauschka PV, Reid ML: Vitamin K dependence of a calcium binding protein containing gamma-carboxy-glutamic acid in chicken bone.J Biol Chem 253: 9063, 1978

    PubMed  CAS  Google Scholar 

  5. Rosenthall L, Kaye M: Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.J Nucl Med 16: 33, 1975

    PubMed  CAS  Google Scholar 

  6. Wiegmann T, Rosenthall L, Kaye M: Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.J Nucl Med 18: 231, 1977

    PubMed  CAS  Google Scholar 

  7. Ling G, Nebel G, Dorr S: Die Bedeutung der Szintimetrie im Vergleich mit Histomorphometrie, Parathormon, Densitometrie und Rontgendiagnostik bei renaler Ostheopathie.Fortschr Geb Rontgenstr Nuklearmed Erganzungsband 136: 9, 1981

    Article  Google Scholar 

  8. Fogelman I, Bessent RG, Turner JG, et al: The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.J Nucl Med 19: 270, 1978

    PubMed  CAS  Google Scholar 

  9. De Graaf P, Pauwels EKJ, Vos PH, et al: Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.Eur J Nucl Med 9:419, 1984

    Article  PubMed  Google Scholar 

  10. Jones AG, Francis MD, Davis MA: Bone scanning: Radionuclidic reaction mechanisms.Semin Nucl Med 6: 3, 1976

    Article  PubMed  CAS  Google Scholar 

  11. Francis MD, Russel RGG, Fleisch H: Diphosphonates inhibition formation of calcium phosphate crystalsin vitro and pathological calcificationin vivo Science 165: 1264, 1969

    Article  PubMed  CAS  Google Scholar 

  12. Rosenthall L, Kaye M: Observations on the mechanism of Tc99m-labeled phosphate complex uptake in metabolic bone disease.Semin Nucl Med 6: 59, 1976

    Article  PubMed  CAS  Google Scholar 

  13. Guillemart A, Besnard JC, LePape A: Skeletal up-take of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.J Nucl Med 19: 895, 1978

    PubMed  CAS  Google Scholar 

  14. Zimmer AM, Isitman AT, Holmes RA: Enzymatic inhibition of diphosphonate: A proposed mechanism of tissue uptake.J Nucl Med 16: 352, 1975

    PubMed  CAS  Google Scholar 

  15. Beresford JN, Gallagher JA, Poser JV, et al: Production of osteocalcin by human bone cellsin vitro: Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids.Metab Bone Dis Rel 5: 229, 1984

    Article  CAS  Google Scholar 

  16. Lian JB, Couttes MC, Canalis E: Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvaria.J Biol Chem 260: 8706, 1985

    PubMed  CAS  Google Scholar 

  17. Brown JP, Delmas PD, Malaval L, et al: Serum bone Glaprotein: A specific marker for bone formation in postmenopausal osteoporosis.Lancet 1: 1091, 1984

    Article  PubMed  CAS  Google Scholar 

  18. Ismail F, Epstein S, Pacifici R, et al: Serum bone GLA protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.Calcif Tissue Int 39: 230, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karayalcin, U., Karayalcin, B., Yakupoglu, G. et al. Tc-99m-HMDP bone uptake quantification and plasma osteocalcin levels in hemodialysis patients—A preliminary study. Ann Nucl Med 6, 9–12 (1992). https://doi.org/10.1007/BF03164636

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164636

Key words

Navigation